The World Health Organization (WHO) says it has recorded success in controlling river blindness in Africa after more than 40 years of sustained efforts.
According to Dr. Matshidiso Moeti, the WHO Regional Director for Africa, in a statement in Abuja on Tuesday while highlighting the organization’s progress in the past two years in the region.
Moeti said a report has shown between 2016-2017, the organization ( WHO) has recorded a significant reduction in HIV related deaths from 800,000 in 2015 to 720,000 in 2016.
The regional director said the report aimed to highlight the progress achieved in emergency preparedness and response, elimination of priority diseases such as HIV, TB and malaria.
She said it also aimed to highlight continuing efforts by the organization in tackling non-communicable diseases, progress in protecting children from illness and deaths, among others.
The organisation wants to ensure Africa becomes polio-free by 2019, over 190,000 polio vaccinators have so far immunized more than 116 million under-five children in 13 countries in West and Central Africa.
“WHO’s reforms in health security including the establishment of the Incident Management System led to effective coordination and deployment of over 2,500 experts in 2016. These experts responded to over 150 public health events including outbreaks such as meningitis, Lassa fever and cholera, as well as the health effects of drought, floods and food insecurity“, she said.
“In 2016, WHO together with Ministries of Health and partners in Angola and the Democratic Republic of the Congo (DRC), vaccinated over 30 million people in a matter of months, to end the largest ever yellow fever outbreak.
Within 48 hours of being notified of the Ebola outbreak in the Likati zone in DR Congo, WHO worked with the country and partners to effectively respond which led to the outbreak being brought to an end within two months.
Togo is the first country in the African Region to achieve WHO’s validation of elimination of lymphatic filariasis as a public health problem,” Moeti added.
She drew attention to the urgent need to address antimicrobial resistance in the region as it has serious implications for treatment failure, rising costs and increased disease burden.
The regional director also said the organization is supporting 44 countries to develop National Action Plans (NAPs) to tackle antimicrobial resistance.
She stated that the organization [s also working with countries in the region to improve diagnostic capacities of TB laboratory services in order to address the growing problem of drug-resistant TB.
According to her, Multidrug-resistant Tuberculosis (MDR-TB) treatment programmes have been established in 40 of the 44 countries that have ever reported a case of MDR-TB.
Moeti said the region also experienced remarkable progress in the protection of children from illness and deaths during the the period of two years“WHO and partners supported the inclusion of pneumococcal conjugate and rotavirus vaccines in the national routine immunization schedules of 38 and 31 countries, respectively.
The RTSS vaccine, which has demonstrated partial protection against the malaria parasite plasmodium falciparum in young children, will be piloted in Kenya, Malawi and Ghana in 2018 and is expected to contribute to reducing child deaths,’’ she said.
The regional director however observed that while national immunization coverage rates were high in many countries, one in five children still do not have access to all the vaccines they need.
She attributed the setback to inequities and coverage gaps associated with household income and the mothers’ education.
Moeti expressed optimism that the problem would be resolved as African Heads of state show commitment to putting into action the Addis Declaration on Immunization (ADI) which was endorsed at the African Union Summit in January 2017.